1. Serum Lipopolysaccharide-binding Protein Levels and the Incidence of Metabolic Syndrome in a General Japanese Population: the Hisayama Study
- Author
-
Shoko Tomooka, Emi Oishi, Masako Asada, Satoko Sakata, Jun Hata, Sanmei Chen, Takanori Honda, Kosuke Suzuki, Hiroshi Watanabe, Norihito Murayama, Naohisa Wada, Takanari Kitazono, and Toshiharu Ninomiya
- Subjects
metabolic syndrome ,endotoxemia ,epidemiology ,follow-up studies ,lipopolysaccharide-binding protein ,Medicine (General) ,R5-920 - Abstract
Background: The association between chronic lipopolysaccharide exposure and the development of metabolic syndrome (MetS) is unclear. In this study we examined the association between serum lipopolysaccharide-binding protein (LBP) levels, an indicator of lipopolysaccharide exposure, and the development of MetS in a general Japanese population. Methods: 1,869 community-dwelling Japanese individuals aged ≥40 years without MetS at baseline examination in 2002–2003 were followed up by repeated examination in 2007–2008. MetS was defined according to the Japanese criteria. Serum LBP levels were classified into quartiles (quartiles 1–4: 2.20–9.56, 9.57–10.78, 10.79–12.18, and 12.19–24.34 µg/mL, respectively). Odds ratios (ORs) for developing MetS were calculated using a logistic regression model. Results: At the follow-up survey, 159 participants had developed MetS. Higher serum LBP levels were associated with greater risk of developing MetS after multivariable adjustment for age, sex, smoking, drinking, and exercise habits (OR [95% confidence interval] for quartiles 1–4: 1.00 [reference], 2.92 [1.59–5.37], 3.48 [1.91–6.35], and 3.86 [2.12–7.03], respectively; P for trend
- Published
- 2024
- Full Text
- View/download PDF